- Home
- ELVN vs FG Comparison
ELVN vs FG Comparison
Compare ELVN & FG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELVN | FG |
|---|---|---|
| Founded | 2016 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2020 | 2023 |
Fundamental Metrics
Financial Performance| Metric | ELVN | FG |
|---|---|---|
| Price | $54.32 | $23.12 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $43.40 | $31.00 |
| AVG Volume (30 Days) | ★ 783.2K | 520.4K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ 1.24 |
| Revenue | N/A | ★ $5,731,000,000.00 |
| Revenue This Year | N/A | $7.94 |
| Revenue Next Year | N/A | $5.51 |
| P/E Ratio | ★ N/A | $19.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $14.79 | $20.57 |
| 52 Week High | $62.32 | $35.33 |
Technical Indicators
Market Signals| Indicator | ELVN | FG |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 37.54 |
| Support Level | $25.63 | $22.18 |
| Resistance Level | $62.16 | $30.12 |
| Average True Range (ATR) | 1.95 | 0.67 |
| MACD | -0.59 | 0.18 |
| Stochastic Oscillator | 1.93 | 36.92 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.